Tuberculosis incidence and the seroprevalence of HIV infection in the United States. NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Tuberculosis incidence and the seroprevalence of HIV infection in the United States.

Am J Prev Med. 1991 Nov-Dec;7(6):422-4. Unique Identifier : AIDSLINE MED/92162396
Levin VR; Department of Internal Medicine, School of Medicine, University; of North Carolina, Chapel Hill.

Abstract: Unlike other available studies, this article not only recognizes a human immunodeficiency virus-tuberculosis (HIV-TB) correlation but also shows its strength, statistical significance, and the method of calculation. These results increase comparability of the data on the HIV-TB relationship and allow more accurate analysis for developing better control of the two diseases. This population-based study compares data by states on HIV seroprevalence among 1,799,771 military recruits and the incidence of TB in the general population of the United States in 1987. The corresponding correlation coefficient was 0.8 (P less than .001). Although military recruits do not constitute a random sampling of the population at risk for TB, the high correlation suggests that HIV infection contributes substantially to population-based rates of TB.
Keywords: Female Human HIV Seropositivity/COMPLICATIONS *HIV Seroprevalence Incidence Male Military Personnel Tuberculosis/COMPLICATIONS/*EPIDEMIOLOGY United States/EPIDEMIOLOGY JOURNAL ARTICLEKWDfemalehumanhivseropositivity/complicationsKWDhivseroprevalenceincidencemalemilitarypersonneltuberculosis/complications/KWDepidemiologyunitedstates/epidemiologyjournalarticle
920630
M9260986

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .